Investment
Features
FeesSafety
Academy
More
Pluang+

Nicole Palermo joins Christie's New York, bringing $700M+ in luxury Manhattan townhouse sales.

Others
16 Oct 2026
GlobeNewsWire
View Source
Neutral
Nicole Palermo joins Christie's New York, bringing $700M+ in luxury Manhattan townhouse sales.

Nicole Palermo, a Manhattan townhouse specialist with over $700 million in career sales, has joined Christie's International Real Estate New York. Known for handling luxury properties above $10 million, Palermo brings extensive expertise and a high-profile client base, including notable sales linked to celebrities. Her addition strengthens Christie's position in the luxury real estate market, leveraging its global network to serve clients worldwide. This move follows recent team expansions at Christie's New York, signaling growth and increased market presence.

Nicole Palermo joining Christie's International Real Estate New York is the story's subject. For readers following the real estate sector, here is Pluang's market snapshot as of Oct 16, 2026 22:21 WIB: 38 of 47 priced US real estate stocks rose while 8 fell. Notable movers include WY at USD 19.68 (+1.55%), BRX at USD 27.84 (+1.51%) with a typical hold time of 1 day, and AMT at USD 184.00 (+1.46%) with Pluang order activity showing 84% Sell and 16% Buy, and a typical hold time of 85 days.

More News

CHMP gives positive opinion on weekly TransCon CNP for treating achondroplasia in children, EU decision due Q4 2026

CHMP gives positive opinion on weekly TransCon CNP for treating achondroplasia in children, EU decision due Q4 2026

Ascendis Pharma announced that the European Medicines Agency's CHMP has given a positive opinion for TransCon CNP (Navepegritid), a once-weekly treatment for achondroplasia in children aged 2 and above with open growth plates. This recommendation sup...

Market News
Bullish
21 minutes ago
EU's CHMP gives positive opinion on weekly TransCon CNP for treating children's achondroplasia

EU's CHMP gives positive opinion on weekly TransCon CNP for treating children's achondroplasia

Ascendis Pharma announced that the European Medicines Agency's CHMP has issued a positive opinion recommending approval of TransCon CNP (navepegritide), a once-weekly treatment for achondroplasia in children aged two and older with open growth plates...

Market News
Bullish
21 minutes ago
US data centers face a 32-gigawatt power shortfall by 2028, pushing Elon Musk to plan AI operations in space.

US data centers face a 32-gigawatt power shortfall by 2028, pushing Elon Musk to plan AI operations in space.

Morgan Stanley reports a 32-gigawatt electricity deficit for US data centers through 2028, a 34% shortfall even after alternative power sources. This power gap threatens AI growth as data centers need constant energy to operate. Tech analyst James Al...

Market News
Neutral
1 hour ago
TAT Technologies remains a Strong Buy despite supply chain challenges and weak cash flow.

TAT Technologies remains a Strong Buy despite supply chain challenges and weak cash flow.

TAT Technologies is rated a Strong Buy due to strong demand for its APU products, expanded agreements with Honeywell, and a growing backlog valued at $615 million. The company reported a 22.8% revenue increase in Q2, but cash flow remains weak becaus...

Analyst Insights
Bullish
4 hours ago
SoundHound AI stock drops 53% in 2026 amid doubts on growth and profitability.

SoundHound AI stock drops 53% in 2026 amid doubts on growth and profitability.

SoundHound AI's stock has fallen 53% in 2026, closing near its 52-week low as investors question its growth and profitability. Despite record Q2 revenue growth of 45% and improved margins, the company remains unprofitable with significant cash outflo...

Technical Signals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App